Innovations TV Series to Highlight on Ennaid Therapeutics, LLC in Upcoming Episode
Wednesday, February 3, 2016
Posted by: Angela King
Ennaid Therapeutics, LLC announced today that they will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing 1Q/2016 via Discovery Channel. Dates and show times TBA.
This episode of Innovations will feature Ennaid Therapeutics, a biopharmaceutical company creating disruptive innovation to safely and rapidly develop cures for mosquito-borne, emerging infectious diseases. Viewers will learn about the company’s development of first-to-market, proprietary therapeutics for the 400 million people worldwide who contract—and the 3 billion people at risk of contracting—dengue virus, the world’s fastest growing pandemic.
“Ennaid Therapeutics welcomes the opportunity to work with the Innovations Series, because of our mutual dedication to developing and promoting the most up-to-date, cutting edge information in industries such as healthcare,” said Darnisha Harrison, CEO and founder of Ennaid Therapeutics. “The Innovations series will help spread the message of practical, innovation and education in healthcare. Issues like Dengue Fever are not limited to residents of tropical zones, but can affect travelers to tropical countries, vacation destinations, cruises and business travel. Innovations will help spread that message of encouragement and hope for millions of people exposed to Dengue Fever and other diseases.”
Ennaid is leading the challenge of developing and bringing innovative cures and leading edge healthcare technologies to formerly incurable disease, and is dedicated to saving lives and improving the health of millions of patients worldwide.
“Ennaid Therapeutics uses its unique, patented platform technology to safely and rapidly develop and commercialize therapeutics for infectious diseases,” said Michele Nehls, Producer for the Innovations Series. “We are proud to inform audiences on the revolutionary technologies at play.”
About Ennaid Therapeutics:
Ennaid Therapeutics is a biopharma company developing cures (not vaccines) to help 400 million people worldwide who contract seemingly incurable diseases, like dengue virus, a life-debilitating, possibly deadly, mosquito-borne virus. Filling a gap not suited for big pharma, the company acquires early-stage, proprietary, innovative science and creates a fast-track development plan to be 1st-to-market with profitable therapeutic cures. For more information, visit: http://www.ennaidtherapeutics.com.
About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.
DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.
For more information visit: http://www.InnovationsTelevision.com or contact Michele Nehls at (866) 496-4065 x 822 or via email at Michele(at)InnovationsTelevision(dot)com.
Source. Pr Web. http://www.prweb.com/releases/2015/10/prweb13028491.htm